Acute Mesenteric Ischemia, Reality in Catalonia
Launched by HOSPITAL DEL MAR · May 20, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Acute Mesenteric Ischemia, Reality in Catalonia," is focused on studying a serious condition known as acute mesenteric ischemia (AMI). This condition occurs when the blood flow to the intestines is reduced, which can lead to severe health problems. The goal of the study is to analyze the outcomes of patients who are admitted to hospitals in Catalonia with AMI.
The trial is looking for participants aged 65 to 74 who have been diagnosed with acute mesenteric ischemia. However, people with certain other conditions, like chronic mesenteric ischemia or bowel obstructions, will not be eligible to participate. If you join this study, you will help researchers understand how to better diagnose and treat AMI, potentially improving care for future patients. It’s important to note that this trial is not yet open for enrollment, so there will be more information available later for those interested in participating.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnostic of Acute Mesenteric Ischemia
- Exclusion Criteria:
- • Chronic Mesenteric Ischemia
- • Ischemic Colitis
- • Bowel obstruction strangulation
- • Inflammatory bowel necrosis
About Hospital Del Mar
Hospital del Mar is a leading healthcare institution located in Barcelona, Spain, renowned for its commitment to medical excellence and patient care. As a prominent clinical trial sponsor, Hospital del Mar actively engages in innovative research aimed at advancing medical knowledge and improving therapeutic outcomes across various specialties. The hospital boasts a multidisciplinary team of experienced researchers and healthcare professionals dedicated to conducting rigorous clinical trials in accordance with the highest ethical and regulatory standards. Through collaboration with academic institutions and industry partners, Hospital del Mar strives to translate research findings into tangible benefits for patients, enhancing the quality of care within the community and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported